BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 25269682)

  • 1. Ferumoxytol-enhanced magnetic resonance angiography is a feasible method for the clinical evaluation of lower extremity arterial disease.
    Walker JP; Nosova E; Sigovan M; Rapp J; Grenon MS; Owens CD; Gasper WJ; Saloner DA
    Ann Vasc Surg; 2015 Jan; 29(1):63-8. PubMed ID: 25269682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feasibility of three-dimensional magnetic resonance angiography-fluoroscopy image fusion technique in guiding complex endovascular aortic procedures in patients with renal insufficiency.
    Schwein A; Chinnadurai P; Shah DJ; Lumsden AB; Bechara CF; Bismuth J
    J Vasc Surg; 2017 May; 65(5):1440-1452. PubMed ID: 28017584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The diagnostic value of non-contrast enhanced quiescent interval single shot (QISS) magnetic resonance angiography at 3T for lower extremity peripheral arterial disease, in comparison to CT angiography.
    Wu G; Yang J; Zhang T; Morelli JN; Giri S; Li X; Tang W
    J Cardiovasc Magn Reson; 2016 Oct; 18(1):71. PubMed ID: 27760564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intermodality feature fusion combining unenhanced computed tomography and ferumoxytol-enhanced magnetic resonance angiography for patient-specific vascular mapping in renal impairment.
    Yoshida T; Nguyen KL; Shahrouki P; Quinones-Baldrich WJ; Lawrence PF; Finn JP
    J Vasc Surg; 2020 May; 71(5):1674-1684. PubMed ID: 31734117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arterial imaging in patients with lower extremity ischemia and diabetes mellitus.
    Pomposelli F
    J Vasc Surg; 2010 Sep; 52(3 Suppl):81S-91S. PubMed ID: 20804938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accuracy of Noncontrast Quiescent-Interval Single-Shot Lower Extremity MR Angiography Versus CT Angiography for Diagnosis of Peripheral Artery Disease: Comparison With Digital Subtraction Angiography.
    Varga-Szemes A; Wichmann JL; Schoepf UJ; Suranyi P; De Cecco CN; Muscogiuri G; Caruso D; Yamada RT; Litwin SE; Tesche C; Duguay TM; Giri S; Vliegenthart R; Todoran TM
    JACC Cardiovasc Imaging; 2017 Oct; 10(10 Pt A):1116-1124. PubMed ID: 28109932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Quiescent-Interval Single-Shot Magnetic Resonance Angiography in Diabetic Patients With Critical Limb Ischemia Undergoing Digital Subtraction Angiography: Comparison With Contrast-Enhanced Magnetic Resonance Angiography With Calf Compression at 3.0 Tesla.
    Wei LM; Zhu YQ; Zhang PL; Lu HT; Zhao JG
    J Endovasc Ther; 2019 Feb; 26(1):44-53. PubMed ID: 30580695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First-pass contrast-enhanced magnetic resonance angiography in humans using ferumoxytol, a novel ultrasmall superparamagnetic iron oxide (USPIO)-based blood pool agent.
    Li W; Tutton S; Vu AT; Pierchala L; Li BS; Lewis JM; Prasad PV; Edelman RR
    J Magn Reson Imaging; 2005 Jan; 21(1):46-52. PubMed ID: 15611942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Whole-body MR angiography in patients with peripheral arterial disease.
    Nielsen YJ
    Dan Med Bull; 2010 Dec; 57(12):B4231. PubMed ID: 21122468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of contrast-enhanced multi-station MR angiography and digital subtraction angiography of the lower extremity arterial disease.
    Burbelko M; Augsten M; Kalinowski MO; Heverhagen JT
    J Magn Reson Imaging; 2013 Jun; 37(6):1427-35. PubMed ID: 23188773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating peripheral arterial disease with unenhanced quiescent-interval single-shot MR angiography at 3 T.
    Amin P; Collins JD; Koktzoglou I; Molvar C; Markl M; Edelman RR; Carr JC
    AJR Am J Roentgenol; 2014 Apr; 202(4):886-93. PubMed ID: 24660721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ferumoxytol magnetic resonance angiography: a dose-finding study in patients with chronic kidney disease.
    Stoumpos S; Hennessy M; Vesey AT; Radjenovic A; Kasthuri R; Kingsmore DB; Mark PB; Roditi G
    Eur Radiol; 2019 Jul; 29(7):3543-3552. PubMed ID: 30919067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-resolution, whole-body vascular imaging with ferumoxytol as an alternative to gadolinium agents in a pediatric chronic kidney disease cohort.
    Nayak AB; Luhar A; Hanudel M; Gales B; Hall TR; Finn JP; Salusky IB; Zaritsky J
    Pediatr Nephrol; 2015 Mar; 30(3):515-21. PubMed ID: 25212105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contrast-enhanced magnetic resonance venography in pediatric patients with chronic kidney disease: initial experience with ferumoxytol.
    Luhar A; Khan S; Finn JP; Ghahremani S; Griggs R; Zaritsky J; Salusky I; Hall TR
    Pediatr Radiol; 2016 Aug; 46(9):1332-40. PubMed ID: 27059620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multi-observer comparison study between unenhanced quiescent-interval single-shot magnetic resonance angiography and invasive carbon dioxide angiography in patients with peripheral arterial disease and chronic renal insufficiency.
    Arendt CT; Leithner D; Lenga L; Wichmann JL; Albrecht MH; Czwikla R; Varga-Szemes A; d'Angelo T; Martin SS; Thalhammer A; Nagel E; Vogl TJ; Gruber-Rouh T
    Eur J Radiol; 2018 Nov; 108():140-146. PubMed ID: 30396647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High resolution, 3-dimensional Ferumoxytol-enhanced cardiovascular magnetic resonance venography in central venous occlusion.
    Shahrouki P; Moriarty JM; Khan SN; Bista B; Kee ST; DeRubertis BG; Yoshida T; Nguyen KL; Finn JP
    J Cardiovasc Magn Reson; 2019 Mar; 21(1):17. PubMed ID: 30853026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-gadolinium-enhanced 3-dimensional magnetic resonance angiography for the evaluation of thoracic aortic disease: a preliminary experience.
    Srichai MB; Kim S; Axel L; Babb J; Hecht EM
    Tex Heart Inst J; 2010; 37(1):58-65. PubMed ID: 20200628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contrast-enhanced 3D MRA with centric ordering in k space: a preliminary clinical experience in imaging the abdominal aorta and renal and peripheral arterial vasculature.
    Shetty AN; Bis KG; Vrachliotis TG; Kirsch M; Shirkhoda A; Ellwood R
    J Magn Reson Imaging; 1998; 8(3):603-15. PubMed ID: 9626875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular Imaging With Ferumoxytol as a Contrast Agent.
    Hope MD; Hope TA; Zhu C; Faraji F; Haraldsson H; Ordovas KG; Saloner D
    AJR Am J Roentgenol; 2015 Sep; 205(3):W366-73. PubMed ID: 26102308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3D non-contrast-enhanced ECG-gated MR angiography of the lower extremities with dual-source radiofrequency transmission at 3.0 T: Intraindividual comparison with contrast-enhanced MR angiography in PAOD patients.
    Rasper M; Wildgruber M; Settles M; Eckstein HH; Zimmermann A; Reeps C; Rummeny EJ; Huber AM
    Eur Radiol; 2016 Sep; 26(9):2871-80. PubMed ID: 26560724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.